During recent decades, nucleic acid aptamers have emerged as powerful biological
recognition elements for electrochemical affinity biosensors. These bioreceptors emulate or …

Heart disease (especially myocardial infarction (MI)) and cancer are major causes of death.
Recently, aptasensors with the applying of different nanostructures have been able to …

Janus nanoparticles (JNPs) refer to the integration of two or more chemically discrepant
composites into one structure system. Studies into JNPs have been of significant interest …

Surface plasmon resonance (SPR) has become a leading technique for in situ bioaffinity
assay of diverse targets without need of fluorescent or enzymatic labeling. Nanomaterials …

One of the most studied topics in analytical chemistry and physics is to develop bio-sensors.
Aptamers are small single-stranded RNA or DNA oligonucleotides (5–25 kDa), which have …

Aptamers are exciting smart molecular probes for specific recognition of disease biomarkers.
A number of strategies have been developed to convert target–aptamer binding into …

Early and timely diagnosis of cancer plays a decisive role in appropriate treatment and
improves clinical outcomes, improving public health. Significant advances in biosensor …

The tunability of SELEX procedure is an essential feature to supply bioaffinity receptors
(aptamers) almost on demand for analytical and therapeutic purposes. This longstanding …

Aptamers are promising biorecognition elements with a wide applicability from therapeutics
to biosensing. However, to successfully use these biomolecules, a complete …

Detection of biomolecules is essential for patient diagnosis, disease management, and
numerous other applications. Recently, nano-and microparticle-based detection has been …